Stronger Effect of Azilsartan on Reduction of Proteinuria Compared to Candesartan in Patients with CKD: A Randomized Crossover Trial

Introduction: Angiotensin receptor blockers (ARBs) are preferably used in hypertensive patients with CKD. Azilsartan is a strong antihypertensive ARB, but its antiproteinuric effects are not well understood. We compared the antiproteinuric effect of azilsartan and candesartan in CKD patients in an o...

Description complète

Détails bibliographiques

Auteurs principaux:	Takaichi Suehiro, Kazuhiko Tsuruya, Hisako Yoshida, Hiroaki Tsujikawa, Shunsuke Yamada, Shigeru Tanaka, Akihiro Tsuchimoto, Masahiro Eriguchi, Kiichiro Fujisaki, Kumiko Torisu, Toshiaki Nakano, Takanari Kitazono
Format:	Artigo
Langue:	Inglês
Publié:	Karger Publishers 2021-03-01
Collection:	Kidney & Blood Pressure Research
Sujets:	azilsartan candesartan ckd crossover trial proteinuria
Accès en ligne:	https://www.karger.com/Article/FullText/512365
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!